I

Incyte

Biopharmaceutical company pursuing drug discovery.

Medical Science Liaison Hematology / Oncology

Biology & BiotechUpdated on Nov 10
Full-timeRemote in GermanyNo salary listed

About the Job

Requirements

  • An advanced scientific or clinical degree, such as a PharmD, PhD, MD, or equivalent, is required.
  • Previous experience in an MSL or related medical function is required; Oncology/Hematology experience is ideal.
  • Fluency in German and strong English skills are required.
  • Willingness to travel across Germany and Europe is required.
  • The candidate should be comfortable managing large territories, multichannel interactions, and evolving stakeholders.

Responsibilities

  • Lead scientific dialogue with hematologists, oncologists, and other key stakeholders, positioning the company as a trusted partner in advancing science and patient care.
  • Drive engagement with external experts, investigators, and scientific bodies through strategic engagement and build authentic, long-term collaborations beyond transactional exchange.
  • Support evidence generation and innovation by facilitating company-sponsored and investigator-initiated research, real-world data projects, and collaborative research.
  • Partner closely with commercial teams to foster early, compliant collaboration and shared understanding, ensuring aligned and impactful market engagement to advance the company's territory footprint.
  • Support new launches in Oncology and Hematology, ensuring the medical voice is strong in a competitive landscape.
  • Represent the company externally at medical congresses, advisory boards, and investigator and expert meetings, embodying its commitment to science, integrity, and collaboration.
  • Bring field insights, feedback, and market intelligence to the organization to inform its decisions.
  • Strengthen internal capabilities through medical training, cross-functional alignment, and communicating science to internal and external audiences.

Desired Qualifications

  • Deep curiosity, resilience, and an intrapreneurial mindset, including the ability to see ambiguity as an opportunity.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs